26 research outputs found

    NGHIÊN CỨU THỰC NGHIỆM TÁC DỤNG GIẢM CHẤN CỦA CÔNG TRÌNH CHỊU TẢI TRỌNG SÓNG XUNG KÍCH DƯỚI NƯỚC Ở QUẦN ĐẢO TRƯỜNG SA

    Get PDF
    Research on the problem of load damping of the structures under the effect of shock waves in environment generally and in water particularly is important and necessary for military structures and buildings of inhabitants. If properly designed and having solution to reduce the effects of the blast wave, general structures will be increased markedly and reduce ability of being destroyed. One of the solutions to reduce the effects of the blast wave is to glue layers of material having capable of absorbing blast waves onto the structures. The theoretical and empirical studies are currently less pronounced due to many different reasons. This paper presents modeling and experimental results from the underwater explosion topic KC09.06/11-15 in Truong Sa archipelago to determine the damping effect of the structure modeling is designed with layers of featured material on  its surface.Nghiên cứu về vấn đề giảm chấn của công trình dưới tác dụng của sóng xung kích trong các môi trường nói chung và môi trường nước nói riêng đều quan trọng và cần thiết đối với công trình quân sự và dân sinh. Nếu được thiết kế hợp lý và có các biện pháp làm giảm tác dụng của sóng nổ thì sức sống của công trình được tăng lên rõ rệt, khả năng bị phá hủy giảm. Một trong những giải pháp giảm tác dụng của sóng nổ là dán lớp vât liệu có khả năng hấp thụ sóng nổ lên kết cấu công trình. Các công trình lý thuyết và thực nghiệm về vấn đề này hiện ít được công bố do nhiều nguyên nhân khác nhau. Bài báo trình bày mô hình và kết quả thí nghiệm nổ dưới nước từ đề tài KC09.06/11-15 tại khu vực Trường Sa nhằm xác định tác dụng giảm chấn của mô hình công trình được thiết kế lớp vật liệu đặc trưng trên bề mặt

    Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    Get PDF

    Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

    Get PDF
    Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

    Present situation and prospect of shelter, living standard and environment improvement for the urban poor in Ho Chi Minh City : final report

    No full text
    Sub-project no. 1; part 2 of

    Socio-economic, housing and environment characteristics of the urban poor in Hanoi : final report

    No full text
    Sub-project no. 1; part 1 of
    corecore